Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

teplizumab

teplizumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tzield INJECTION, INTRAVENOUS 1 mg/mL      
Comments:

Restricted to endocrinology provider use in the hospital outpatient infusion center through patient specific prescriptions supplied via Huntsville Hospital Specialty Pharmacy. Huntsville Hospital reimbursement and insurance certification or PAP eligibility will be reviewed prior to initiation of therapy.

 

 

 

 

 

Reviewed: November 2025        

Teplizumab (TZIELD) Spotlight1.pdf

Last updated: Dec. 18, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved